John Franklin Fowler - 14 Feb 2025 Form 4 Insider Report for Kezar Life Sciences, Inc. (KZR)

Role
Director
Signature
/s/ Marc Belsky, Attorney-in-Fact
Issuer symbol
KZR
Transactions as of
14 Feb 2025
Net transactions value
$0
Form type
4
Filing time
14 Feb 2025, 18:53:56 UTC
Previous filing
26 Jul 2023
Next filing
23 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KZR Stock Option (right to buy) Award $0 +5,000 $0.000000 5,000 14 Feb 2025 Common Stock 5,000 $5.89 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-hundred percent (100%) of the shares subject to the option shall vest on February 1, 2026, subject to Reporting Person continuing to provide service through such date.